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Growth plateDuring endochondral bone formation, chondrocytes undergo differentiation toward hypertrophy before they
are replaced by bone and bone marrow. In this study, we found that a G-protein coupled receptor CXCR4 is
predominantly expressed in hypertrophic chondrocytes, while its ligand, chemokine stromal cell-derived
factor 1 (SDF-1) is expressed in the bone marrow adjacent to hypertrophic chondrocytes. Thus, they are
expressed in a complementary pattern in the chondro-osseous junction of the growth plate. Transfection of
a CXCR4 cDNA into pre-hypertrophic chondrocytes results in a dose-dependent increase of hypertrophic
markers including Runx2, Col X, and MMP-13 in response to SDF-1 treatment. In organ culture SDF-1
inﬁltrates cartilage and accelerates growth plate hypertrophy. Furthermore, a continuous infusion of SDF-1
into the rabbit proximal tibial physis results in early physeal closure, which is accompanied by a transient
elevation of type X collagen expression. Blocking SDF-1/CXCR4 interaction suppresses the expression of
Runx2. Thus, interaction of SDF-1 and CXCR4 is required for Runx2 expression. Interestingly, knocking down
Runx2 gene expression results in a decrease of CXCR4 mRNA levels in hypertrophic chondrocytes. This
suggests a positive feedback loop of stimulation of chondrocyte hypertrophy by SDF-1/CXCR4, which is
mediated by Runx2.s, The Warren Alpert Medical
Suite 402A, 1 Hoppin Street,
n_Chen@brown.edu (Q. Chen).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
All long bones in the vertebrate limb are developed through a
process called endochondral bone formation, in which bone is formed
from a cartilage anlage. The growth of the cartilage anlage, which is
called a growth plate, determines the size and shape of the long bone.
This morphogenic process is uniquely regulated by pathways within
the growth plate and tissues adjacent to the growth plate cartilage.
One of these neighboring tissues is the bone marrow located at the
base of the growth plate adjacent to the hypertrophic zone.
The hypertrophic chondrocyte is an important regulatory cell
during endochondral bone formation because bone lengthening is
driven primarily by the rate of differentiation of the hypertrophic
chondrocytes from proliferating chondrocytes. Type X collagen and
matrix metalloprotease 13 (MMP-13) are well-known molecular
markers up-regulated during chondrocyte hypertrophy (Schmid andLinsenmayer, 1985),while Runt-related transcription factor 2 (Runx2)
is a transcription factor that promotes chondrocyte hypertrophy
(Wang et al., 2004). Runx2(−/−) mice lack hypertrophic chondro-
cytes, while targeted expression of Runx2 in non-hypertrophic
chondrocytes accelerates chondrocyte differentiation and leads to
maturation of chondrocytes that do not normally become hypertro-
phic (Ducy et al., 1997; Komori et al., 1997). Previous studies have
shown that the degradation of hypertrophic cartilage requires the
presence of bone marrow (Cole et al., 1992). However, the molecular
mechanism of this induction remains elusive.We hypothesize that the
induction of hypertrophic matrix degradationmay involve chemokine
stromal cell-derived factor 1 (SDF-1) secreted by cells in the bone
marrow area adjacent to the hypertrophic cartilage in the chondro-
osseous junction.
Chemokines are soluble peptides that regulate cell movement,
morphology, proliferation, and differentiation (Pulsatelli et al., 1999).
Chemokines achieve their regulation by signaling through a family of
seven transmembrane G-protein coupled receptors. SDF-1 is an 8 kDa
peptide originally isolated from a bone marrow stromal cell line (Jo
et al., 2000), which activates various primary cells by binding solely to
its receptor, CXCR4 (Mohle et al., 1998; Pulsatelli et al., 1999). SDF-1
is also found in other cells, including endothelial cells and osteoblasts
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shown previously that SDF-1 and its receptor CXCR4 play an im-
portant role in cell migration, embryonic development, and human
immunodeﬁciency virus infection. SDF-1 signaling is important
during development and morphogenesis, as both SDF-1 and CXCR4
knockout mice exhibit signiﬁcant developmental abnormalities that
lead to embryonic lethality (Ma et al., 1998). The goal of this study
is to determine the distribution pattern of SDF-1 and its receptor
CXCR4 in the growth plate, and to determine whether SDF-1/CXCR4
signaling regulates chondrocyte differentiation during endochondral
bone formation.
Materials and methods
Generation of retrovirus containing CXCR4 cDNA
CXCR4 cDNA was cloned into a myc-tagged retroviral vector
(RCAS) by RT-PCR from total RNA isolated from chick sternal cartilage
with primers 5′-CAT GCC ATG GCA ATG GAC GGT TTG GAT-3′, and 5′-
CAT GCC ATG GCA GCT GGA ATG GAA ACT TGA-3′ (sequence from 60
to 1133), designed according to a DNA sequence from GenBank™
(accession number AF294794) (Table 1). PCR products were digested
with ClaI and ligated into a RCAS vector. RCAS–CXCR4 was sequenced
to ensure no spontaneous mutations during subcloning. CDNAs con-
tained myc as a marker of the exogenously transfected product.
CXCR4–RCAS and empty RCAS vector were transfected into chicken
embryonic ﬁbroblasts respectively, and the virus was harvested from
the medium as previously described (Chen et al., 1995). Medium from
ﬁbroblasts not transfected (mock) was also collected as a control.
Primary chick chondrocyte isolation and culture
Primary cultures of chick embryonic chondrocytes were estab-
lished as described previously (Chen et al., 1995; Gibson and Flint,
1985). Caudal (proliferative), middle (pre-hypertrophic), and cephal-
ic (hypertrophic) parts of the sterna from 17-day-old embryonic
chickens were separated under a dissection microscope. They were
subjected to enzymatic treatment with 0.1% trypsin (Sigma-Aldrich,
St. Louis, MO), 0.3% collagenase (Worthington, Freehold, NJ), and
0.1% type 1 testicular hyaluronidase (Sigma-Aldrich, St. Louis, MO)
(dissociation medium). After incubating for 30 min. at 37 °C, the dis-
sociation medium was removed and replaced with fresh dissociation
medium and incubated at 37 °C for an additional 1 h. Chondrocytes
were resuspended in plating medium plus 0.01% testicular hyaluron-Table 1
Gene Primer Sequence
RT-PCR oligonucleotide primer sequences used for detection of target genes' mRNA
CXCR4
(1073 bp)
Forward 5′-CAT GCC ATG GCA ATG GAC GGT TTG GAT-3′
Reverse 5′-CAT GCC ATG GCA GCT GGA ATG GAA ACT TGA-3′
MMP-13
(1280 bp)
Forward 5′-ATT TAA CGT ACA GAA TTA TGA GTT ACA CAT-3′
Reverse 5′-TTC CTT CCT GTT TTC CTA TTA ATT TAA TGC-3′
GPDH
(1001 bp)
Forward 5′-ATG GTG AAA GTC GGA GTC AAC GGA TTT-3′
Reverse 5′-TCA CTC CTT GGA TGC CAT GTG GAC CAT CAA-3′












Forward 5′-AGT GCT GTC ATT GAT CTC ATG GA-3′
Reverse 5′-TCA GAG GAA TAG AGA CCA TTG GAT T-3′
Runx2
(181 bp)
Forward 5′-CTT CGC CGT CCA TTC ACT CC-3′




Reverse 5′-GCTGGAATTACCGCGGCT-3′idase (plating medium: 10% fetal bovine serum in Ham F-12 medium;
Gibco, Grand Island, NY). After culturing overnight, the medium of
the chondrocyte culture was replaced with fresh medium without
hyaluronidase. Medium was changed every other day.Chondrocyte cell transfection
Primary chicken chondrocytes were cultured as previously de-
scribed (Chen et al., 1995). When cell cultures became 50% conﬂuent,
cells were infected with retrovirus conditional medium containing
RCAS/CXCR4, or empty RCAS, or mock (no virus). After a four-day
incubation, transfected cells were analyzed by immunocytochemistry
with a mAb against myc-tag (9B11 Cell signaling, Danvers, MA) to
conﬁrm the infection. Before collecting samples for experiment, the
cells were stimulated with SDF-1 (100 ng/mL; Cat# 351-FS, R&D
Systems, Inc. Minneapolis, MN) for 24 h or pretreated with AMD3100
for 2 h (5 µg/mL; Cat# 155148-31-5, Sigma-Aldrich, St. Louis, MO),
a speciﬁc inhibitor for CXCR4, before stimulation with SDF-1. In some
cases, the cells were transfected with full length Runx2 cDNA plasmid
(a gift from Dr. D. Chen, Rochester University) or Runx2-siRNA
(Dharmacon Com. Lafayette, CO).Immunocytochemistry
After a four-day incubation, transfected cells were analyzed by
immunocytochemistry with a mAb against myc-tag (1:200, Cat# 9B11,
Cell Signaling, Danvers, MA). The transfected cells on 8 chamber poly-
styrene vessel tissue culture treated glass slides (REF 354108, BD Bio-
sciences, Bedford, MA) were ﬁxed at−20 °C with 70% ethanol, 50 mM
glycine, and pH 2.0 for 20 min. Slides were then washed with PBS and
incubated with primary antibodies. After washing with PBS, afﬁnity-
puriﬁed TRITC conjugated donkey anti-mouse antibodies (1:500,
Jackson ImmunoResearch, West Grove, PA) were applied with Hoechst
nuclear dye (0.5 mg/mL). Slides were washed and mounted in 95%
glycerol in PBS. Single or multiple exposure photography was per-
formed with a Nikon E800 microscope (Melville, NY).Organ culture
Whole sterna were isolated from 15-day-old embryonic chickens
and cultured in HBSS containing synthetic SDF-1 peptide (100 ng/mL;
351-FS, R&D Systems, Inc. Minneapolis, MN) for 1 h, 3 h, and 24 h.
Tibia growth plates were isolated from 12-day-old embryonic chicken
and cultured in F12 containing 10% FBS and, synthetic SDF-1 peptide
(100 ng/mL) for 2, 4, and6 days. The sampleswere collected, embedded
in Tissue Tek (Sakura Finetechanical Co., Ltd., Tokyo, Japan), and
subjected to frozen sectioning. Ten µm sections were analyzed by
immunohistochemistrywith amAbagainst SDF-1 (25 µg/mL;MAB310,
R&D Systems, Inc. Minneapolis, MN) or with a mAb against type X
collagen (1:2 dilution; Cat# X-AC-9, Developmental Studies Hybridoma
Bank, Iowa City, IA). To detect the distribution of Runx2 in growth plate,
10 µm sections from one-day-old mice tibia growth plates (C57BL/6)
were analyzed by immuno-ﬂuorescent stainingwith a rabbit Ab against
Runx2 (1:200; Cat# AB/RNT20, CeMines, Inc. Golden, Co.). The sections
were ﬁxed at−20 °C with 70% ethanol, 50 mM glycine, and pH 2.0 for
20 min. Slides were then washed with PBS and incubated with primary
antibody. After washing with PBS, afﬁnity-puriﬁed TRITC conjugated
donkey anti-mouse antibody or afﬁnity-puriﬁed FITC conjugated
donkey anti-rabbit antibody (1:500, Jackson ImmunoResearch, West
Grove, PA) was applied with Hoechst nuclear dye (0.5 mg/mL). The
sections were washed and mounted in 95% glycerol in PBS. Single
or multiple exposure photography was performed with a Nikon E800
microscope (Melville, NY).
Fig. 1. Distribution of SDF-1 and CXCR4 in the growth plate. Immunohistochemical staining for CXCR4 and SDF1 was performed on one-day-old mouse proximal tibial growth plates.
CXCR4 expression was strongest in the hypertrophic zone (red color) (A), while SDF-1 was most strongly expressed in bone marrow (red color) adjacent to the hypertrophic
chondrocytes(B). Scale bar=20 µm.
Fig. 2. Expressions of CXCR4, type X, and Runx2 in proliferative, pre-hypertrophic, and
hypertrophic chondrocytes. Total RNA was isolated from three different zones of 17-
day-old chicken embryonic sterna and qRT-PCR was carried out to quantitate CXCR4
mRNA. CXCR4 mRNA was much higher in hypertrophic chondrocytes than in
proliferative and pre-hypertrophic chondrocytes (A), similar to the up-regulation of
hypertrophic markers type X collagen and Runx2 (B). Bar graphs show the averages of
quantiﬁed data from three independent experiments using Real time PCR. *: pb0.05
compared to proliferative chondrocytes.
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To detect the distribution of CXCR4 and SDF-1 in growth plate, the
knee joints from one-day-old mice (C57BL/6) were ﬁxed overnight in
4% paraformaldehyde in phosphate-buffered saline (pH 7.4), dehy-
drated in ethanol, cleared in xylene, and embedded in parafﬁn. Ten
µm sections were prepared and collected on positively charged glass
slides (Superfrost Plus, Fisher Scientiﬁc). The sections were dried on a
hot plate to increase adherence to the slides. Immunohistochemistry
was carried out using the Histostain-SP Kits (Zymed, Cat# 95-9943).
Sections were de-parafﬁned and re-hydrated through conventional
methods. Endogenous peroxidase was blocked by treating the sec-
tions with 3% hydrogen peroxide in methanol for 30 min. The sections
were digested by 5 mg/mL hyaluronidase (Cat# H3506, Sigma-
Aldrich, St. Louis, MO) for 20 min. Nonspeciﬁc protein binding was
blocked by incubation with a serum blocking solution. The sections
were incubated with afﬁnity-isolated Ig G fractions of monoclonal
mouse Ab against human CXCR4 (25 µg/mL; Cat# MAB171 R&D
Systems, Inc., Minneapolis, MN) and a mAb against SDF-1 (25 µg/mL;
Cat# MAB310 R&D Systems, Inc., Minneapolis, MN) respectively at
4 °C overnight. The negative control sections were incubated with
isotype control (25 µg/mL; Cat# MAB002 R&D Systems, Inc., Min-
neapolis, MN) in 0.01 M PBS. Thereafter, the sections were treated
sequentially with ready to use biotinylated secondary antibody and
ready to use streptavidin–peroxidase conjugate (Zymed), and then
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(Zymed). The sections were counterstained with ready to use hema-
toxylin (Zymed). Photography was performed with a Nikon E800
microscope (Melville, NY).Reverse transcriptase-polymerase chain reaction (RT-PCR)
Seventeen-day-old embryonic chicken sterna were separated into
three parts under a dissection microscope: lower third/caudal (prolif-
erative zone), middle (pre-hypertrophic zone), and upper third/ce-
phalic (hypertrophic zone). Total RNA was extracted from each zone
using RNeasy mini kit (Qiagen, Valencia, CA) according to the
manufacturer's protocol. First-strand complementary DNA (cDNA)
was made from 1 µg of total RNA with Superscript II reverse tran-
scriptase (Gibco BRL) following the manufacturer's protocol. PrimersFig. 3. SDF-1/CXCR4 induction of chondrocyte hypertrophy. To determine whether SDF-1
chondrocytes was infected with chicken ﬁbroblast conditional medium containing RCAS–CX
expression in proliferative chondrocytes transfected with RACS–CXCR4 was detected by imm
red color for CXCR4). qRT-PCR was performed for MMP-13 (B) and type X collagen (C). MM
chondrocytes transfectedwith RCAS–CXCR4with SDF-1 in a dose-dependent manner. Simila
of quantiﬁed data of type X collagen using Real time PCR from three independent experimen
bar=20 µm. CECs: chicken embryonic proliferative chondrocytes.used in ampliﬁcation of target genes mRNA are shown in Table 1. PCR
reactions were performed as follows: 40 cycles with the GoldTaq PCR
system (Perkin Elmer, Norwalk, CT) at 94 °C for 30 s, 50 °C for 1 min,
and 72 °C for 2 min. GAPDH housekeeping genemRNAwas ampliﬁed at
the same time as the internal control. The ampliﬁed cDNA fragments
were detected by electrophoresis in 1.2% (weight/volume) agarose gels.Real time PCR
After cells were incubated with SDF-1 for 24 h, total RNA was
isolated with the RNeasy mini kit (QIAGEN). One µg total of RNA was
reverse transcribed with the iScript™ cDNA Synthesis Kit (Bio-Rad,
Hercules, CA). Real time quantitative PCR ampliﬁcationwas performed
using the QuantiTect SYBR Green PCR kit (QIAGEN, Valencia, CA) with
the DNA Engine Opticon 2 Continuous Fluorescence Detection System/CXCR4 signaling induces chondrocytes hypertrophy, 50% conﬂuency of proliferative
CR4 or RCAS alone for 4 days and then treated with 100 ng SDF-1/mL for 1 day. CXCR4
uno-ﬂuorescent staining with myc-tag antibody but not in RACS transfected group (A,
P-13 and type X collagen mRNA expression increased after treatment of proliferative
r results were observed in three experiments for mmp-13. Bar graphs show the averages
ts. *: Signiﬁcant difference in comparison to the non-SDF-1 treated group, pb0.05. Scale
Fig. 4. SDF-1 can diffuse into cartilage. To determine whether SDF-1 can diffuse into
cartilage, 17-day chicken embryonic sternal cartilage was incubated with SDF-1
(100 ng/mL) or without SDF-1 for 1 h, 3 h, and 24 h. Ten µm frozen sections were used
to detect SDF-1 by immuno-ﬂuorescent staining with mAb against SDF-1. Fluorescence
microscopy showed a progressive increase in SDF-1 staining (red color) surrounding
chondrocytes during the 24 h time course (A, B,C) compared to control at 24 h (D).
Scale bar=20 µm.
240 L. Wei et al. / Developmental Biology 341 (2010) 236–245(MJ Research, Waltham, MA). Primers used in ampliﬁcation of target
genes mRNA are shown in Table 1. mRNA levels were normalized to
18S mRNA levels (Zhen et al., 2001). Calculation of mRNA values
was performed as previously described (Wei et al., 2006). The cycle
threshold (Ct) values for 18S RNA and that of samples were measured
and calculated by computer software (MJ Research, Waltham, MA).
Relative transcription levels were calculated as x=2−ΔΔCt, in which
ΔΔCt=ΔE−ΔC, and ΔE=Ctexp−Ct18s; ΔC=Ctctl−Ct18s.
In vivo infusion of SDF-1 in rabbit tibial physis
The study was approved by the Institutional Animal Care and Use
Committee of Rhode Island Hospital. The animals were a subset
of those used for a previous study (Lee et al., 2007). A continuous
infusion system consisting of a fenestrated catheter and an osmotic
pump were implanted into the right proximal tibial physis of twenty
six-week-old New Zealand White rabbits (Millbrook Breeding Labs,
Amherst, MA). Ten animals received an osmotic pump loaded with
human recombinant SDF-1α (PeproTech, Rocky Hill, New Jersey) at a
concentration of 250 µg/mL in phosphate-buffered saline solution for
4 weeks (SDF-1-treated group). The sham-treated group consisted of
ten rabbits implanted with a pump housing phosphate-buffered
saline solution for 4 weeks. The catheter was inserted into the growth
plate cartilage and after 8 weeks was in the subchondral bonemarrow
region due to growth.
Two rabbits were randomly chosen from both the SDF-1-treated
group and the sham-treated group at 2 and 4 weeks after implanta-
tion. The animals were killed with a sodium pentobarbital overdose
(100 mg/kg). The remaining rabbits from each group were killed at
8 weeks with use of the same method. The proximal part of the tibiae
from the rabbits was harvested, placed in 4% paraformaldehyde for
2 days, decalciﬁed in Richman–Gelfand–Hill solution for 16 h, washed
with tap water for 8 h, dehydrated with serial ethanol and xylene
washes, and then were embedded in parafﬁn. Multiple 6-µm sections
were obtained and stained with hematoxylin and eosin as well as
safranin O for histological analysis.
To quantify the mRNA level of type X collagen, a Paradise FFPE
Reagent System kit (Molecular Devices, Sunnyvale, CA) was used to
extract and amplify RNA from laser captured cells (Sabo et al., 2008).
In brief, 6-µm sections were air dried and dehydrated through graded
alcohols, and subjected to laser captured microdissection (LCM)
within 2 h of deparafﬁnization. Five thousand cells were micro-
dissected from the proliferative and hypertrophic zone tissue sections
respectively and captured on LCM Macro CapSure caps (Molecular
Devices) using an AutoPix Automated LCM instrument (Molecular
Devices). The quantiﬁcation of mRNA was performed by Real time
PCR using the QuantiTect SYBR Green PCR kit (QIAGEN, Valencia, CA)
with the DNA Engine Opticon 2 Continuous Fluorescence Detection
System (MJ Research, Waltham, MA). Primers (5′–3′) for rabbit
Type X collagen were: forward, CCAGTGAGAGGAGAACAAGG; reverse,
TGGCACAGAAATGCCAGCTG (Access number: AF247705, 306 bp).
Ampliﬁcation conditions were as follows: 2 min preincubation at
50 °C, 10 min at 95 °C for enzyme activation, and 40 cycles at 95 °C
denaturation for 10 s, 55 °C annealing for 30 s and 72 °C extension
for 30 s. The comparative threshold cycle (Ct) method, i.e., 2−ΔΔCt
method was used for the calculation of fold ampliﬁcation (Wei et al.,
2006).
Statistical analysis
Two-tailed t-tests were used to compare mRNA levels from pro-
liferative chondrocyte to hypertrophic chondrocytes. MRNA levels in
chondrocytes under different conditions were analyzed by one-way
ANOVA with the Dunnett Multiple Comparison post-hoc test at a
rejection level of 5% unless speciﬁcally noted.Results
Distribution of CXCR4 and SDF-1 in a growth plate
As the ﬁrst step to evaluate the potential role of the SDF-1/CXCR4
axis in the growth plate, we analyzed distribution of SDF-1 and its
receptor CXCR4 in tibial growth plates from one-day-old mice by
immunohistochemistry (Fig. 1). SDF-1 receptor, CXCR4, was strongly
expressed in the hypertrophic zone of the growth plate, while weak
expression was found in the proliferative and pre-hypertrophic zones
(Fig. 1A, red color). SDF-1 was present at very low levels in growth
plate cartilage in comparison to its strong expression in the bone
marrow area adjacent to the hypertrophic zone of the growth plate
(Fig. 1B, brown color).
Expression levels of CXCR4, type X collagen, and Runx2 in the growth
plate
To quantify the expression levels of CXCR4 in different zones
of growth plates, we used embryonic chicken sterna, which were
separated into the three different zones under a dissectionmicroscope.
Quantitative real time RT-PCR analysis indicated that CXCR4 mRNA
wasmost highly expressed in hypertrophic chondrocytes, while it was
expressed at very low levels in the proliferating or pre-hypertrophic
chondrocytes (Figs. 2A, B). This is similar to the up-regulation of type
X collagen and Runx2 mRNA in hypertrophic chondrocytes (Fig. 2B).
SDF-1/CXCR4 interaction stimulates chondrocyte hypertrophy
To test whether the interaction of SDF-1 and CXCR4 stimulates
chondrocyte hypertrophy, we cloned a full length CXCR4 cDNA from
chicken growth plate chondrocytes and then cloned it into a retroviral
vector RCAS. The RCAS–CXCR4 cDNA was then transfected into
241L. Wei et al. / Developmental Biology 341 (2010) 236–245proliferative chondrocytes (Fig. 3A). Cells transfected with CXCR4
showed a signiﬁcant increase of type X collagen and MMP-13 mRNA
levels in response to SDF-1 treatment in a dose-dependent manner
(Figs. 3B and C). In contrast, proliferative chondrocytes transfected
with empty vector RCAS had no increase in the mRNA levels of type X
collagen or MMP13 in response to SDF-1 treatment.
SDF-1 inﬁltrates cartilage tissue and accelerates growth plate hypertrophy
To determine whether SDF-1 could conceivably diffuse into
growth plate cartilage tissue from adjacent tissue, sternal cartilage
was incubated with 100 ng/mL SDF-1 for 1, 3, and 24 h in organ
culture. Immunohistochemistry was performed to detect SDF-1 inFig. 5. SDF-1 accelerates growth plate chondrocyte hypertrophy in organ culture. To conﬁrm
growth plates were cultured in the presence of SDF-1 (100 ng/mL) or in the absence of SD
expression by immuno-ﬂuorescent staining with mAb against type X collagen. A progressive
was seen. The ratio of the length of the hypertrophic zone to that of the total growth platecartilage tissue using a mAb against SDF-1. While SDF-1 was barely
detectable after 1 h incubation (Fig. 4A), a faint staining of SDF-1 was
detected around chondrocytes after 3 h incubation (Fig. 4B). SDF-1
was detected surrounding many chondrocytes after 24 h incubation
(Fig. 4C). This suggests that SDF-1 is capable of diffusing into cartilage
tissue and interacting with chondrocytes.
To further test whether SDF-1 induces chondrocyte hypertrophy in
organ culture, entire tibia cartilaginous growth plates were dissected
from 12-day-old chicken embryos and incubated in the presence or
absence of SDF-1 (100 ng/mL) for 2, 4, and 6 days. Immunohisto-
chemical analysis with a mAb against type X collagen was performed
to determine the length of the hypertrophic zone. Compared to non-
SDF-1 treated samples, the length of the hypertrophic zone wasthat SDF-1 induces chondrocyte hypertrophy in growth plates, 12-day-old chicken tibia
F-1 for 2, 4, and 6 days. Ten µm frozen sections were used to detect type X collagen
increase in the size of the hypertrophic growth plate based on type X collagen staining
was calculated at the different time points (B). (*pb0.05). Scale bar=100 µm.
Fig. 6. SDF-1/CXCR4 signaling regulates Runx2 expression. Fifty percent conﬂuent
proliferative chondrocytes were infected with RACS–CXCR4 or RCAS for 4 days and then
treated with 100 ng/mL SDF-1 for 1 day. Real time PCR was used to quantify Runx2
gene expression and western blot was used to detect Runx2 protein levels. (A) Runx2
mRNA expression increased after RACS–CXCR4 transfection and SDF-1 exposure,
however, the increase of Runx2 expressionwas inhibited by CXCR4 inhibitor AMD3100.
*pb0.05 compared to RACS; #: compared to RACS–CXCR4 and SDF-1 treatment. (B)
Western blot showed similar changes in Runx2 protein.
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further increased after incubation for 6 days (Fig. 5). The decrease
of the length of the proliferative and pre-hypertrophic zones in the
SDF-1 treated growth plate was also accelerated, possibly due to an
increase of the conversion rate to hypertrophy.Fig. 7. Runx2 regulates CXCR4, MMP-13, and type X collagen expression. 2.5×105
hypertrophic chondrocytes from 17-day chicken sterna embryo were seeded in F12
culture medium overnight and transfected with 1 µg human full length Runx2 DNA or
co-transfected with 1 µg human full length Runx2 DNA combined with Runx2 Si RNA
(5 nM/mL) 2 days in 6-well plates. mRNA levels of CXCR4, MMP-13, and type X
collagen were quantiﬁed by Real time PCR. Over-expression of Runx2 increased CXCR4
(A), MMP-13 (B), and type X collagen expression while down-regulation of Runx2
using SiRNA inhibited their endogenicity and Runx2 induction of CXCR4, MMP-13, andSDF-1/CXCR4 interaction stimulates Runx2 expression
To test whether SDF-1 treatment of chondrocytes induces Runx2,
proliferating chondrocytes were incubated with 100 ng/mL SDF-1
after transfection with CXCR4 or empty vector. Real time RT-PCR
results indicated that SDF-1 induced Runx2 mRNA expression in
chondrocytes transfected with CXCR4 expression construct (Fig. 6A).
Furthermore, this induction of Runx2 was partially inhibited by
AMD3100, a speciﬁc inhibitor of CXCR4 (Fig. 6A). Western blot results
show that the changes in Runx2 protein levels were similar to the
changes in Runx2 mRNA (Fig. 6B).type X collagen expression. *: Signiﬁcant difference in comparison to mock control,
pb0.05. #: Statistically signiﬁcant in comparison to Runx2 treatment alone.Runx2 regulates CXCR4, MMP-13, and type X collagen expression
To determine whether up-regulation of CXCR4 in hypertrophic
chondrocytes was dependent on Runx2 expression, hypertrophic
chondrocytes from 17-day-old chicken embryo sterna were trans-
fected with Runx2 SiRNA and/or Runx2 cDNA. Over-expression of
Runx2 resulted in an increase of CXCR4 (Fig. 7A), MMP-13 (Fig. 7B),
and type X collagen mRNA levels (Fig. 7C), while knocking down
Runx2 expression led to a decrease of CXCR4, MMP-13, and type X
collagen mRNA levels (Figs. 7A, B, and C).SDF-1 induces physeal closure and stimulates type X collagen expression
in rabbit proximal tibial physis
To determine the effect of activating the SDF-1/CXCR4 pathway on
regulation of chondrocyte differentiation in vivo, human recombinant
SDF-1 (250 µg/mL) or PBS controls were administrated into a growth
plate in vivo by using a continuous infusion system, consisting of a
fenestrated catheter and an osmotic pump implanted into the right
243L. Wei et al. / Developmental Biology 341 (2010) 236–245proximal tibial physis of twenty six-week-old New Zealand White
rabbits. As we reported previously, in the SDF-1-treated group,
the SDF-1-treated leg demonstrated a signiﬁcant decrease in length
of 3.7±3.1 mm compared with the control leg (p=0.006; Lee et al.,
2007). Histologic analysis indicates a marked difference in physeal
morphology between the SDF-1-treated and PBS-treated groups at
the eight-week time-point. The PBS-treated physes demonstrated a
normal column cellular arrangement (Fig. 8A-a), while the SDF-1-
treated physes were narrowed with gross disruption of the columnar
organization. The border between the residual proliferative and hy-
pertrophic zones of SDF-1-treated physes was indistinct, and the
cartilage column was replaced by vessels and new bone formation,
similar to normal physeal closure (Fig. 8B-a). To determine whether
the SDF-1 induced physeal closure involves stimulation of chondro-
cyte hypertrophy, 5000 cells were microdissected through laser cap-
ture from the proliferative and hypertrophic zones of the proximal
tibial physis respectively (Fig. 8A-b and 8A-c). Five thousand cellsFig. 8. SDF-1 infusion results in the tibial physeal closure and stimulates type X collagen expr
PBS (No-SDF-1 treatment) for 8 weeks were stained with safranin O for gross morphology
capture with captured area indicated by blue shade (A-b, A-c and B-c). The PBS-treated co
hypertrophic zone. The SDF-1-treated rabbit physis (B-a) exhibits marked thinning wit
disorganization of cell columns; scattered hypertrophic chondrocytes; and vascular, as wel
consistent with physeal closure. Brackets on two photomicrographs (A-c and B-c) indicate
lacuna. Cells were microdissected from the proliferative and hypertrophic zones respectivel
SDF-1-treated physis (B-c). Real time PCR results indicate that the expression of type X mRN
signiﬁcantly increased in the hypertrophic zone of the SDF-1-treated physis at four-week tim
level in the remnant cartilage when the growth plate was closed after the physis was treatwere also microdissected from the residual growth plate without
distinction between the proliferative and hypertrophic zones in the
physes treated with SDF-1 for 8 weeks (Fig. 8B-c). Real time RT-PCR
results demonstrated that in controls, type X collagen expression was
only detectable in the hypertrophic zone and the residual growth
plate, but not in the proliferative zone. After SDF-1 treatment for
4 weeks, Col X mRNA levels were increased in the hypertrophic zone
compared to control (Fig. 8C). After SDF-1 treatment for 2 weeks,
Col X mRNA levels were not increased compared to control. The Col X
mRNA level in the residual growth plate of the eight-week SDF-1
treatment group was equivalent to that in the hypertrophic zone of
the control rabbits (Fig. 8C).
Discussion
The cartilaginous growth plate determines the size and shape of a
long bone by maintaining sequential differentiation of chondrocytesession. Tissue sections of rabbit proximal tibiae treated with SDF-1 (SDF-1 treatment) or
(A-a and B-a). Unstained sections were used for chondrocyte microdissection by laser
ntrol rabbit physis (A-a) demonstrates normal growth plate morphology with a distal
hout distinction between proliferative and hypertrophic zone remnants. There was
l as osseous, invasion into the growth plate remnant (B-a and B-b). These features are
the height of the physis, deﬁned from the resting zone to the last intact hypertrophic
y in the control physis (A-b and A-c), and from the remnant of the growth plate in the
A was not detectable in the proliferative chondrocytes. Type X collagen expression was
e point in comparison to those from the PBS-treated physis, and remained at the same
ed with SDF-1 for 8 weeks (C).
Fig. 8 (continued).
244 L. Wei et al. / Developmental Biology 341 (2010) 236–245from proliferation to hypertrophy, and by regulating the production
rate of hypertrophic chondrocytes. Misregulation of this process
may lead to chondrodysplasia. The signaling pathways regulating
growth plate chondrocyte hypertrophy are not completely under-
stood. There are two major transition points regulating chondrocyte
hypertrophy. The ﬁrst is the entry of the hypertrophic stage from
proliferation, which occurs mainly in the pre-hypertrophic zone that
expresses the Ihh and PTHrP receptors. Previous studies have sug-
gested a negative feedback loop in which Ihh induces PTHrP at the
proximal end of the growth plate, whose interaction with its receptor
in the pre-hypertrophic zone potently inhibits chondrocyte entry
into hypertrophy (Vortkamp et al., 1996). The second transition point
is the exit of hypertrophic cartilage to bone, which occurs at the
chondro-osseous junction. Previous studies have shown that this
transition requires degradation of hypertrophic cartilage, which is
not only mediated by metalloproteinases including MMP 9 and 13 in
hypertrophic chondrocytes (Vu et al., 1998), but also is induced by the
presence of cells from the bone marrow area in the chondro-osseous
junction (Cole et al., 1992). However, the molecular nature of this
induction remains elusive.
Our study suggests that the chemokine stromal cell-derived factor
1 (SDF-1) may be involved in this process. We found that SDF-1 and
its receptor CXCR4 are expressed in a complementary pattern at the
chondro-osseous junction in the growth plate, with hypertrophic
cartilage positive for the receptor CXCR4, and its adjacent bonemarrowexpressing the ligand SDF-1. Interestingly, such a complementary
expression pattern of SDF-1/CXCR4 exists in a wide variety of opposed
tissue pairs during development, including gastrular mesoderm/
ectoderm, vascular endothelium/mesoderm, thyroid endodermal epi-
thelium/mesenchyme, and nasal ectodermal epithelium/mesenchyme
(McGrath et al., 1999). Such a complementary gene expression pat-
tern results in a paracrine regulatory mechanism in which an SDF-1
producing tissue induces the development of the opposing tissue that
expresses CXCR4. Based on this complementary gene expression pat-
tern in thegrowthplate,wehypothesized that SDF-1 frombonemarrow
induces and/or enhances differentiation and degradation of hypertro-
phic cartilage, which expresses CXCR4.
In this study, we tested this hypothesis directly by examining the
role of the chemokine SDF-1 and its receptor CXCR4 in this regulatory
process in cells, organ cultures, and in vivo. We found that transfection
of CXCR4 into proliferative chondrocytes resulted in a dose-depen-
dent increase of MMP-13 and type X collagen in response to SDF-1
treatment. Both MMP-13 and type X collagen are well-known
markers for hypertrophic chondrocytes. In organ culture, SDF-1 is
capable of diffusing into sternal cartilage rapidly and accumulates
around chondrocytes. This suggests that SDF-1 synthesized by cells in
bonemarrowmay be capable of diffusing into the adjacent cartilage in
the chondro-osseous junction. Previous data have shown that SDF-1
binds to glycosaminoglycans in the extracellular matrix or on the cell
surface (Fermas et al., 2008; Uchimura et al., 2006; Mbemba et al.,
1999). Such binding may stabilize SDF-1 and result in its accumula-
tion around chondrocytes.
We have shown that, when a tibia growth plate was incubated
with SDF-1, SDF-1 stimulated elongation of the hypertrophic zone at
the distal end of the growth plate towards the proximal end. However,
it did not result in a neo hypertrophic zone at the top of the growth
plate. How is this polarity achieved? Our data suggest that this zone
speciﬁc induction may be due to the speciﬁc expression of the SDF-1
receptor CXCR4 in the hypertrophic cartilage. We have shown that
induction of hypertrophic chondrocyte markers, including Runx2,
Col X, and MMP-13 in chondrocytes, requires the presence and
interaction of both SDF-1 and CXCR4. In organ culture, although SDF-1
inﬁltrates the growth plate tissue in all directions, only the distal
region of a growth plate contains CXCR4, and this is the area where
hypertrophy is enhanced by SDF-1. Since a major source of SDF-1
in vivo is from cells in the bone marrow area at the chondro-osseous
junction adjacent to the hypertrophic cartilage, these cells may be
involved in inducing the hypertrophic cartilage phenotype including
synthesis of type X collagen and MMP-13 (Inada et al., 2004).
The in vivo effects of SDF-1 on gene expression in the growth plate
were consistent with our in vitro ﬁndings. Elevation of SDF-1 con-
centration in rabbit growth plates in vivo leads to increased type X
collagen gene expression, degradation of the cartilage matrix, poten-
tially from MMP-13, and premature closure of the growth plate (Lee
et al., 2007). Thus, the closure of growth plate in the SDF-1-treated
physis is associated with stimulation of chondrocyte hypertrophy.
Interaction of SDF-1 and CXCR4 in articular chondrocytes results in
up-regulation and release of MMP-3, -9, and -13 (Kanbe et al., 2002;
Kanbe et al., 2004). Interestingly, high concentration of SDF-1, which
occurs in the synovium of rheumatoid arthritis and osteoarthritis
patients, results in death of articular chondrocytes (LeiWei et al., 2006).
Since chondrocytes from the hypertrophic zone of a growth plate and
those fromOAarticular cartilage share somecommon features including
up-regulation of Col X and MMP-13, one may hypothesize that a high
concentration of SDF-1mayalso contribute to cell death occurring in the
chondro-osseous junction in the growth plate, similar to that in OA
cartilage. This hypothesis remains to be tested.
Our study reveals a role for Runx2, a transcription factor critical for
bone formation (Dong et al., 2006; Ducy et al., 1997; Kamekura et al.,
2006; Komori et al., 1997; Yoshida et al., 2004; Zou et al., 2006) in
regulating chondrocyte hypertrophy by SDF-1/CXCR4 signaling. This
245L. Wei et al. / Developmental Biology 341 (2010) 236–245role is twofold. First, Runx2 mediates SDF-1 induction of chondrocyte
hypertrophy.We have shown that treating the CXCR4 cDNA transfected
proliferating chondrocytes with SDF-1 resulted in a signiﬁcant increase
of Runx2 mRNA and protein levels. Runx2, in turn, was involved in
activating Col X expression. Recent data have shown that SDF-1 also
regulates osteoblast properties through Runx2 (Zhu et al., 2007).
Second, Runx2 up-regulates CXCR4 in hypertrophic chondrocytes.
Through Runx2 over-expression and knock-down experiments, we
demonstrated that Runx2 plays an important role for CXCR4 expression
in hypertrophic chondrocytes. Thus, our ﬁndings suggest a positive
feedback loop in which Runx2 regulates chondrocyte differentiation
through activation of SDF-1/CXCR4 signaling; and activation of SDF-1/
CXCR4 signaling further enhances Runx2 expression, thereby inducing
chondrocyte hypertrophy.
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